INNATE PHARMA (EPA:IPH) | WebDisclosure

Basculer en Français

10465	Companies
220121	Keywords
149442	Articles
116378	Press releases

Home
Companies
INNATE PHARMA

PRESS RELEASE

published on 09/02/2025 at 07:00, 8 months 26 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Innate Pharma releases the total number of shares (92,185,473 ordinary shares, 6,419 Preferred Shares 2016, 7,581 Preferred Shares 2017) and voting rights (92,962,943 theoretical, 92,944,368 exercisable) as of September 1, 2025 in compliance with regulations

Voting Rights Shares Stock Market Regulations Innate Pharma
PRESS RELEASE

published on 09/02/2025 at 07:00, 8 months 26 days ago

Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Innate Pharma publie le nombre d'actions et de droits de vote au 1er septembre 2025 selon les régulations AMF. Détails du capital social et des droits de vote

Droits De Vote Biotechnologie Actions AMF Innate Pharma
BRIEF

published on 08/04/2025 at 07:05, 9 months 24 days ago

New number of shares and voting rights for Innate Pharma

AMF Financial Update Shares And Voting Rights Commercial Code Innate Pharma
BRIEF

published on 08/04/2025 at 07:05, 9 months 24 days ago

Nouveau nombre d'actions et de droits de vote pour Innate Pharma

Code De Commerce AMF Innate Pharma Actions Et Droits De Vote Actualisation Financière
PRESS RELEASE

published on 08/04/2025 at 07:00, 9 months 24 days ago

Inside Information / Other news releases
Innate Pharma discloses total shares outstanding and voting rights as of August 1, 2025. The company is a global biotech developing immunotherapies for cancer patients

Voting Rights Biotechnology Immunotherapy Innate Pharma Shares Outstanding
PRESS RELEASE

published on 08/04/2025 at 07:00, 9 months 24 days ago

Informations privilégiées / Autres communiqués
Innate Pharma publie son nouveau nombre d'actions et de droits de vote au 1er août 2025 selon les réglementations de l'AMF. Détails ci-dessous

Nombre D'actions Droits De Vote AMF Innate Pharma Biotechnologies
BRIEF

published on 07/04/2025 at 07:05, 10 months 24 days ago

Innate Pharma annonce une mise à jour de ses actions et de ses droits de vote

Euronext Actions Nasdaq Droit De Vote Innate Pharma
BRIEF

published on 07/04/2025 at 07:05, 10 months 24 days ago

Innate Pharma Announces Share and Voting Rights Update

Voting Rights Shares Euronext Nasdaq Innate Pharma
PRESS RELEASE

published on 07/04/2025 at 07:00, 10 months 24 days ago

Inside Information / Other news releases
Innate Pharma discloses number of shares and voting rights as of July 3, 2025, in accordance with French regulations. Total shares: 92,183,523. Total voting rights: 92,962,943 (theoretical) and 92,944,368 (exercisable)

Voting Rights Shares French Regulations Financial Disclosure Innate Pharma
BRIEF

published on 06/17/2025 at 07:05, 11 months 11 days ago

Innate Pharma to Participate in Key Investor Conferences

Biotechnology Investor Conferences Healthcare Immunotherapy Innate Pharma

Accesswire

Published on 05/28/2026 at 12:30, 13 minutes ago

White Gold Corp. Commences 2026 Exploration Program Designed to Further Increase Known Gold Resources and Make New Discoveries on its District Scale Land Package in Yukon, Canada
Published on 05/28/2026 at 10:30, 2 hours 13 minutes ago

Caldwell Strengthens Financial Services and Fintech Capabilities with Addition of Alex Langridge in London
Published on 05/28/2026 at 10:10, 2 hours 33 minutes ago

Powering Macau's Smart Future with AI - MACAU Pass and Ant Bank (Macao) Partner with Alibaba Ecosystem to Showcase Smart City Vision at BEYOND Expo
Published on 05/28/2026 at 09:05, 3 hours 38 minutes ago

Tocvan Intersects Three New Gold-Silver Zones at Gran Pilar Project Exploration Drilling; Provides Pilot Mine Development Update
Published on 05/28/2026 at 09:01, 3 hours 42 minutes ago

Discovery Energy Metals Corp. Mobilizes Crews for Surface Sampling Program at Crystal Lake Cu-Mo Project, British Columbia

View all ACCESSWIRE

EQS Group

Published on 05/28/2026 at 12:30, 13 minutes ago

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Published on 05/28/2026 at 12:25, 18 minutes ago

Infosys and Roland-Garros Serve Up AI-Powered Digital Fan Experiences, Extend Partnership Through 2031
Published on 05/28/2026 at 11:50, 53 minutes ago

Energiekontor AG: Energiekontor resolves share cancellation
Published on 05/28/2026 at 11:38, 1 hour 5 minutes ago

EQS-Adhoc: Energiekontor AG: Energiekontor AG resolves to buy back shares
Published on 05/28/2026 at 11:05, 1 hour 38 minutes ago

Omdia Q1 2026: Hisense Strengthens Global Leadership in 100-inch+ TVs

Les Echos

Published on 05/28/2026 at 10:30, 2 hours 13 minutes ago

Recticel Group opgenomen in Financial Times-lijst van Europese Klimaatleiders
Published on 05/28/2026 at 10:30, 2 hours 13 minutes ago

Recticel Group included in Top 100 Financial Times list of Europe’s Climate Leaders
Published on 05/28/2026 at 08:45, 3 hours 58 minutes ago

Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski
Published on 05/28/2026 at 08:45, 3 hours 58 minutes ago

Nomination de Mikael Frenkian en qualité de Directeur Général de Baikowski
Published on 05/28/2026 at 08:30, 4 hours 13 minutes ago

Cegedim Business Services renforce sa conformité et sa sécurité avec deux distinctions majeures

View all LES ECHOS COMFI WIRE